Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine versus ropivacaine for pain after lumbar fusion surgery
IRCT20251225068439N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of bupivacaine and ropivacaine in postoperative pain (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Severity of pain, Level of agitation and 2 more. Started Mar 2026; status: completed.
02
Drugs
bupivacaineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20251225068439N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251225068439N1.